CONSONANCE CAPITAL MANAGEMENT LP

Company

Kiniksa Pharmaceuticals International, plc

Filed

June 16, 2020

Accession Number

0001085146-20-001669

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →